POSASR

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

POSASR 1 d883109dposasr.htm POSASR POSASR

As filed with the Securities and Exchange Commission on August 16, 2024

Registration No. 333-269937

Registration No. 333-278971

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-269937

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-278971

UNDER

THE SECURITIES ACT OF 1933

MORPHIC HOLDING, INC.

(Exact name of registrant as specified in its charter)

Delaware

47-3878772

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

35 Gatehouse Drive, A2

Waltham, MA

02451

(781) 996-0955

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Michael C. Thompson

President and Treasurer

Morphic Holding, Inc.

Lilly Corporate Center

Indianapolis, Indiana 46285

(Name and address of agent for service)

(317) 276-2000

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copy to:

Sophia Hudson, P.C.

Sharon Freiman

Kirkland & Ellis LLP

601 Lexington Avenue

New York, New York 10022

Telephone: (212) 446-4800

(Approximate date of commencement of proposed sale to the public): Not applicable.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☒

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

DEREGISTRATION OF SECURITIES

These Post-Effective Amendments (these “Post-Effective Amendments”) filed by Morphic Holding, Inc. (the “Registrant”) relate to the following registration statements on Form S-3 (together, the “Registration Statements”):

Registration Statement No. 333-269937, filed with the U.S. Securities and Exchange Commission (the “Commission”) on February 23, 2023, which became effective automatically upon filing, registering the potential offering and sale by the selling stockholders identified therein of up to 2,828,853 shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”), consisting of (i) 848,655 outstanding shares of Common Stock held by certain of the selling stockholders and (ii) 1,980,198 shares of Common Stock issuable to certain of the selling stockholders upon exercise of certain outstanding pre-funded warrants held by such selling stockholders; and

Registration Statement No. 333-278971, filed with the Commission on April 26, 2024, which became effective automatically upon filing, registering (i) the offering, issuance and sale by the Registrant of an unlimited amount of (a) Common Stock, (b) preferred stock, par value $0.0001 per share, (c) debt securities, (d) warrants to purchase Common Stock, preferred stock or debt securities, (e) subscription rights to purchase Common Stock, preferred stock or debt securities and/or (f) units consisting of some or all of the foregoing securities and (ii) the offering, issuance and sale by the Registrant of up to $350,000,000 of Common Stock pursuant to the Sales Agreement dated April 26, 2024 between the Registrant and TD Securities (USA) LLC, as sales agent.

On August 16, 2024, pursuant to the Agreement and Plan of Merger, dated July 7, 2024 (the “Merger Agreement”), by and among the Registrant, Eli Lilly and Company (“Parent”) and Rainier Acquisition Corporation (“Purchaser”), Purchaser merged with and into the Registrant (the “Merger”), with the Registrant continuing as the surviving corporation and becoming a wholly-owned subsidiary of Parent. As a result of the transactions contemplated by the Merger Agreement, the Registrant has terminated any and all offerings and sales of securities pursuant to the Registration Statements. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities of the Registrant registered under the Registration Statements which remain unsold at the termination of the offering, the Registrant hereby terminates the effectiveness of the Registration Statements and removes from registration all of the securities that remain unsold under the Registration Statements as of the date hereof, if any.

The Registrant is filing these Post-Effective Amendments to withdraw and remove from registration all securities registered pursuant to the Registration Statements that remain unsold as of the date hereof. The Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities. After giving effect to these Post-Effective Amendments, there will be no remaining securities registered by the Registrant pursuant to the Registration Statements.

SIGNATURE

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Indianapolis, Indiana, on August 16, 2024.


MORPHIC HOLDING, INC.

By:		/s/ Michael C. Thompson
Name:		Michael C. Thompson
Title:		President and Treasurer

Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign these Post-Effective Amendments.

SEC Form POSASR filed by Morphic Holding Inc.